Clorox (NYSE:CLX) Given New $171.00 Price Target at DA Davidson

Clorox (NYSE:CLX) had its target price lifted by DA Davidson from $153.00 to $171.00 in a research report report published on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox’s Q2 2025 earnings at $1.27 EPS.

Several other equities research analysts have also recently weighed in on the stock. Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Barclays lifted their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday. JPMorgan Chase & Co. upped their price objective on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, TD Cowen started coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $151.57.

Clorox Stock Down 0.4 %

CLX opened at $162.48 on Monday. The company has a market capitalization of $20.11 billion, a PE ratio of 56.61, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41. The firm has a 50-day simple moving average of $161.63 and a two-hundred day simple moving average of $146.33. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. Clorox has a 52 week low of $125.46 and a 52 week high of $169.09.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share. Analysts forecast that Clorox will post 6.81 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Institutional Trading of Clorox

A number of institutional investors have recently made changes to their positions in CLX. SG Americas Securities LLC raised its stake in Clorox by 1,525.7% in the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after buying an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC raised its position in shares of Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Clorox by 15.2% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after purchasing an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. grew its position in Clorox by 257.5% during the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Raymond James & Associates increased its stake in Clorox by 32.8% during the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock valued at $36,524,000 after purchasing an additional 66,149 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.